VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ASCO GI 2021 | PANTHERA: pembrolizumab, trastuzumab, and chemotherapy in HER2+ advanced gastric cancer

Hyun C. Chung, MD, PhD, Yonsei Cancer Center, Seoul, Republic of Korea, discusses the ongoing PANTHERA trial (NCT02901301), a multi-institutional Phase Ib/II trial of first-line triplet regimen (pembrolizumab, trastuzumab, and chemotherapy) for HER2-positive advanced gastric and gastroesophageal junction cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter